Search Result "LNCaP xenograft"

Research Article

Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice

Journal: Clinical Cancer Drugs
Volume: 7 Issue: 2 Year: 2020 Page: 113-118
Author(s): Vadim S. Pokrovsky,Vladimir A. Zolottsev,Alexandra S. Latysheva,Vasiliy A. Kudinov,Natalia Yu Anisimova,R.L.M. Almanza,Olga Yu Alekseeva,Konstantin K. Baskaev,Galina B. Smirnova,Yulia A. Borisova,Olga M. Ipatova

Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 10 Year: 2015 Page: 1285-1296
Author(s): Livia Carvalho Ferreira,Ali S. Arbab,Bruna Victorasso Jardim-Perassi,Thaiz Ferraz Borin,Nadimpalli RS Varma,ASM Iskander,Adarsh Shankar,Meser M. Ali,Debora Aparecida Pires de Campos Zuccari

Preclinical Evaluation of a Monoclonal Antibody (3C6) Specific for Prostate-Specific Membrane Antigen

Journal: Current Radiopharmaceuticals
Volume: 2 Issue: 1 Year: 2009 Page: 9-17
Author(s): C. A.S. Regino, K. J. Wong, D. E. Milenic, E. H. Holmes, K. Garmestani, P. L. Choyke, M. W. Brechbiel

CDK Inhibitors Induce Mitochondria-mediated Apoptosis Through the Activation of Polyamine Catabolic Pathway in LNCaP, DU145 and PC3 Prostate Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 180-188
Author(s): Elif Damla Arisan, Pinar Obakan, Ajda Coker-Gurkan, Annarica Calcabrini, Enzo Agostinelli, Narcin Palavan Unsal

Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 9 Year: 2014 Page: 860-871
Author(s): Rui Zhou,Zongliang Lu,Kai Liu,Jing Guo,Jie Liu,Yong Zhou,Jian Yang,Mantian Mi,Hongxia Xu

Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration

Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 1184-1191
Author(s): E. Hiltbrand, G. Fournet, J-P. Giliberto, M-J. Paret, J. Chantepie, D. Morel, J. Gore, U. Reichert, H. Mehier, M-E. Rochedix, G. Quash

Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 468-474
Author(s): Esther Sirignano,Assunta Pisano,Anna Caruso,Carmela Saturnino,Maria Stefania Sinicropi,Rosamaria Lappano,Antonio Botta,Domenico Iacopetta,Marcello Maggiolini,Pasquale Longo

Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 144-157
Author(s): J. Dulinska-Litewka,J.A. McCubrey,P. Laidler

Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 1803-1811
Author(s): Ines Graca, Elsa J. Sousa, Tiago Baptista, Mafalda Almeida, Joao Ramalho-Carvalho, Carlos Palmeira, Rui Henrique, Carmen Jeronimo

Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach

Journal: Protein & Peptide Letters
Volume: 23 Issue: 4 Year: 2016 Page: 336-342
Author(s): Javad Rezaei, Masoumeh RajabiBazl, Walead Ebrahimizadeh, Gholamreza Rafiei Dehbidi, Hossien Hosseini

Previous   Next

Go To   Results 1 - 1 of 712

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy